NEOGENOMICS INC — Director's Dealing 2015

Dec 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2015-12-29

Reporting Person: HOREL ROBERT H. (Vice President GM PathLogic)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-29	Common Stock	M	26218	$1.45	Acquired	26218	Direct
2015-12-29	Common Stock	M	25000	$1.69	Acquired	51218	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-29	Stock Option (Right to Buy)	$1.45	X	26218	Acquired	2016-05-20	Common Stock (26218)	Direct
2015-12-29	Stock Option (Right to Buy)	$1.69	X	25000	Acquired	2017-04-12	Common Stock (25000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.78	2020-05-06	Common Stock (50000)	50000	Direct

Footnotes

F1: On May 20, 2011, Mr. Horel was granted 50,000 stock options. These options vest ratably over the first four anniversaries of the grant date. On December 19, 2014, Mr. Horel exercised 23,782 options leaving a balance of 26,218.

F2: On April 12, 2012, Mr. Horel was granted 25,000 stock options. 6,250 options vested immediately and 6,250 options vest on each of the next three anniversaries of the grant date.

F3: On May 6, 2015, Mr. Horel was granted 50,000 stock options. These options vest ratably over the next three years on the anniversary date from the date of the grant.